Those aspiring to outpace the market meticulously engage in the process of selecting individual stocks. Strategic choices can be instrumental in accelerating your wealth.
After finishing at $10.23 in the prior trading day, Genius Sports Limited (NYSE: GENI) closed at $10.19, down -0.39%. In other words, the price has decreased by -$0.39 from its previous closing price. On the day, 3.26 million shares were traded. GENI stock price reached its highest trading level at $10.33 during the session, while it also had its lowest trading level at $9.93.
Ratios:
Our goal is to gain a better understanding of GENI by taking a closer look at its different ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 12.42 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 39.56. For the most recent quarter (mrq), Quick Ratio is recorded 1.73 and its Current Ratio is at 1.73. In the meantime, Its Debt-to-Equity ratio is 0.04 whereas as Long-Term Debt/Eq ratio is at 0.04.
On November 18, 2025, Wells Fargo started tracking the stock assigning a Equal Weight rating and target price of $10.
On September 12, 2025, Roth Capital started tracking the stock assigning a Buy rating and target price of $16.Roth Capital initiated its Buy rating on September 12, 2025, with a $16 target price.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Jan 12 ’26 when Russell Thomas bought 193,514 shares for $10.30 per share.
Taylor Nicholas Charles Fraser bought 199,719 shares of GENI for $2,084,827 on Jan 08 ’26. On Jan 07 ’26, another insider, Locke Mark, who serves as the Officer of the company, bought 53,679 shares for $10.36 each.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, GENI now has a Market Capitalization of 2432537344 and an Enterprise Value of 2254921728. For the stock, the TTM Price-to-Sale (P/S) ratio is 4.27 while its Price-to-Book (P/B) ratio in mrq is 3.42. Its current Enterprise Value per Revenue stands at 3.73 whereas that against EBITDA is -24.226.
Stock Price History:
The Beta on a monthly basis for GENI is 1.84, which has changed by 0.17316508 over the last 52 weeks, in comparison to a change of 0.1726681 over the same period for the S&P500. Over the past 52 weeks, GENI has reached a high of $13.73, while it has fallen to a 52-week low of $8.15. The 50-Day Moving Average of the stock is -2.44%, while the 200-Day Moving Average is calculated to be -6.85%.
Shares Statistics:
The stock has traded on average 5.21M shares per day over the past 3-months and 4278150 shares per day over the last 10 days, according to various share statistics. A total of 242.82M shares are outstanding, with a floating share count of 219.42M. Insiders hold about 8.08% of the company’s shares, while institutions hold 92.79% stake in the company. Shares short for GENI as of 1767139200 were 14702536 with a Short Ratio of 2.82, compared to 1764288000 on 23491727. Therefore, it implies a Short% of Shares Outstanding of 14702536 and a Short% of Float of 6.74.
Earnings Estimates
Genius Sports Limited (GENI) is presently subject to a detailed evaluation by 1.0 analysts, each offering their unique perspectives on its market standing.The consensus estimate for the next quarter is -$0.03, with high estimates of $0.02 and low estimates of -$0.06.
Analysts are recommending an EPS of between $0.3 and $0.3 for the fiscal current year, implying an average EPS of $0.3. EPS for the following year is $0.41, with 1.0 analysts recommending between $0.41 and $0.41.
Revenue Estimates
17 analysts predict $227.21M in revenue. The current quarter. It ranges from a high estimate of $237M to a low estimate of $225.8M. As of. The current estimate, Genius Sports Limited’s year-ago sales were $175.53MFor the next quarter, 17 analysts are estimating revenue of $175.02M. There is a high estimate of $184M for the next quarter, whereas the lowest estimate is $167.12M.
A total of 17 analysts have provided revenue estimates for GENI’s current fiscal year. The highest revenue estimate was $666.1M, while the lowest revenue estimate was $654.8M, resulting in an average revenue estimate of $656.21M. In the same quarter a year ago, actual revenue was $510.89MBased on 17 analysts’ estimates, the company’s revenue will be $789.2M in the next fiscal year. The high estimate is $838.2M and the low estimate is $751.65M.
